So, I will just touch on CapEx, on your previous question on your cost, I also wanted to point out that on the cost side, we are making tremendous progress on the back-end assembly and test cost reductions as well as managing, transforming our supply chain operations, which will give us significant cost benefits as well. So, all-in all, 2019 and beyond, feel very good about our technology roadmap, manufacturing roadmap, capability as well as overall cost capabilities. In terms of, on the CapEx side, just keep in mind, that we have said that with the adjustments that we just have made, over wafer equipment CapEx actually is coming down in fiscal year 2019 versus fiscal year 2018. And as we've discussed before, Micron over the last few years have significantly underinvested in clean room shell CapEx in the facilities and the buildings that are needed to really implement ongoing future technology transition and big part of our CapEx as we have shared with you the past, actually is going towards buildings and facilities, clean room that will be needed for future technology transitions as well. All of that CapEx does not contribute to bit growth. And similarly, we have significant increase in our CapEx in fiscal year 2019 over fiscal year 2018 on back-end test and assembly operations as well. And that is again intended to reduce costs, and not -- it doesn't go towards any bit growth. And we have flexibility, as we have shown already, in terms of managing CapEx. We will continue to look at this carefully and if any factors require us to change our CapEx outlook again, we will absolutely address it in a timely and prudent fashion. We always continue to evaluate market environment as well as our own status of technology, transitions, production requirements, and we are making real-time adjustments as needed.